Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Compugen Ltd (NQ: CGEN )

0.9600 -0.0300 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,012,390
Open 1.010
Bid (Size) 0.9800 (200)
Ask (Size) 1.020 (10)
Prev. Close 0.9900
Today's Range 0.9600 - 1.100
52wk Range 0.5100 - 3.570
Shares Outstanding 86,433,432
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
 
Via Benzinga
Why Shares of Compugen Rose on Thursday
The clinical-stage biotech retreated a bit from one of its biggest days in a while. 
Via The Motley Fool

Performance

YTD
+35.21%
+35.21%
1 Month
+10.61%
+10.61%
3 Month
+11.77%
+11.77%
6 Month
-35.14%
-35.14%
1 Year
-69.91%
-69.91%

More News

Read More
Why Shares of Compugen Rose 16.5% on Wednesday
Via The Motley Fool
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Why Compugen Stock Crumbled Today
Via The Motley Fool
Why Shares of Compugen Jumped 9.27% on Tuesday
Via The Motley Fool
Analyst Ratings for Compugen
Via Benzinga
Why Shares of Compugen Jumped 17.86% on Thursday
Via The Motley Fool
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Compugen: Q2 Earnings Insights
Via Benzinga
Recap: Compugen Q1 Earnings
Via Benzinga
Earnings Scheduled For May 16, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
5 Top Stocks Cathie Wood Sold This Week
Via InvestorPlace
Truist Securities Maintains Buy Rating for Compugen: Here's What You Need To Know
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Cathie Wood Scoops Up Over $20M Worth Of Fate Therapeutics Shares, Dumps More Twitter Stock
Via Benzinga
JMP Securities Maintains Market Outperform Rating for Compugen: Here's What You Need To Know
Via Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
Via Benzinga
Earnings Preview For Compugen
Via Benzinga
Earnings Outlook For Compugen
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.